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Abstract
Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial inflammation that can lead to 
structural damage of cartilage, bone and tendons. Assessing the inflammatory activity and the severity is essential in RA to 
help rheumatologists in adopting proper therapeutic strategies and in evaluating disease outcome and response to treatment. 
In the last years musculoskeletal (MS) ultrasonography (US) underwent tremendous technological development of equipment 
with increased sensitivity in detecting a wide set of joint and soft tissues abnormalities. In RA MSUS with the use of Doppler 
modalities is a useful imaging tool to depict inflammatory abnormalities (i.e. synovitis, tenosynovitis and bursitis) and struc-
tural changes (i.e. bone erosions, cartilage damage and tendon lesions). In addition, MSUS has been demonstrated to be able 
to monitor the response to different therapies in RA to guide local diagnostic and therapeutic procedures such as biopsy, fluid 
aspirations and injections. Future applications based on the development of new tools may improve the role of MSUS in RA. 
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Introduction
Rheumatoid arthritis (RA) is a multifactorial, chron-
ic, systemic, inflammatory disease affecting primarily the 
joints [1]. The disease affects approximately 0.5-1% of 
population and leads into progressive joint destruction 
responsible of disability, restriction of daily living and 
deterioration of quality of life [2]. The need of an early 
suppression of inflammatory process, to prevent the bone 
erosive damage, determined the introduction, in the daily 
clinical practice, of new imaging modalities to identify 
signs of disease activity in early phases [3]. 
Musculoskeletal (MS) ultrasound (US) has been 
widely employed in the assessment and monitoring of 
rheumatic diseases, particularly in patients affected by 
RA. Thanks to its characteristic of validity, reliability re-
producibility and sensitivity to change, US superseded 
other commonly used imaging modalities, such as plain 
radiography (X-ray), and its use has been included in the 
daily routine clinical practice in rheumatology [4]. 
US technique includes the use of gray scale (GS) im-
aging and Doppler modalities. GS images the anatomic 
structures and Doppler shows blood flow. Their use is 
indicated for the evaluation of peri- and intra-articular 
structures, providing an accurate depiction of soft tissue 
and bony cortex changes at all stages of the disease [4] 
(fig 1, fig 2). 
The standardisation of the technique is a relevant as-
pect for US.  In 2001 the EULAR guidelines indicated 
the standard scans to perform at each joint for the evalua-
tion of articular and peri-articular structures [5]. In 2005, 
the OMERACT group published consensus US defini-
tions for common pathologic lesions observed in patients 
affected by RA [6]. According with the OMERACT 
indications, synovial fluid was defined as an abnormal 
hypoechoic or anechoic intra-articular material that is 
displaceable and compressible, and that does not exhibit 
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Fig 1. Grey-scale and PD US of the hand and wrist in rheumatoid arthritis patients. A: Dorsal longitudinal scan 
of the 2nd metacarpophalangeal joint showing signs of synovitis on B-mode modality; B: Dorsal longitudinal 
scan of the 2nd metacarpophalangeal joint showing signs of active synovitis with local hypervascularization
on power Doppler modality; C,D: Transverse (C) and longitudinal (D) scans of extensor carpi ulnaris tendon 
showing signs of tenosynovitis on power Doppler modality. : joint effusion; : synovial hypertrophy; 
: effusion within the tendon sheath; : synovial hypertrophy within the tendon sheath.
Fig 2. Gray-scale US in rheumatoid arthritis 
patients. A1, A2: Dorsal longitudinal (A1) and 
transverse (A2) scan of the right ulnar epiphysis
showing the presence of bone erosions (arrows);
B: Suprapatellar longitudinal scan of the left knee
showing signs of synovitis. : joint effusion; 
: synovial hypertrophy.
Doppler signal; synovial hypertrophy as an abnormal 
hypoechoic intra-articular tissue that is non-displaceable 
and poorly compressible and that may exhibit Doppler 
signal; tenosynovitis as hypoechoic or anechoic thick-
ened tissue with or without fluid within the tendon sheath 
that is seen in 2 perpendicular planes, and that may ex-
hibit Doppler signal; finally, bone erosion as an intra-
articular discontinuity of the bone surface that is visible 
in 2 perpendicular planes [6]. US can be usefully applied 
in the assessment and monitoring of patients affected by 
RA. Several studies demonstrated a great sensitivity of 
US in the detection of signs of inflammation compared 
with the clinical assessment and in the evaluation of bone 
erosive damage, compared with X-ray [4,7-9].
Inflammatory changes
a) Synovitis 
Synovitis is a key feature of RA. An inflammatory sta-
tus at joint level is characterized by the presence of synovi-
al effusion and/or hypertrophy and by the increase of local 
vascularization. In the presence of synovial hypertrophy, 
the application of power Doppler (PD) and color Doppler 
(CD) techniques can help in differentiating between active 
and inactive inflammation [10]. The term of synovitis is 
used to indicate the presence of synovial hypertrophy with 
PD signal and joint effusion. Changes in PD reflect modifi-
cations of disease activity, and the presence of PD has been 
associated with development of erosions [11]. 
The OMERACT Task Force suggested the application 
of a standardized scoring system, combining GS and PD, 
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based on consensus definitions and standardized acquisi-
tion protocol [12,13].  Semiquantitative scoring systems 
have been developed, to assess the changes over time: 
the most commonly used ranges from 0 to 3, according 
to the severity of the alteration, being 0=absent, 1=mild, 
2=moderate, 3=severe. This score is usually calculated 
for each variable analysed (synovial fluid, synovial hy-
pertrophy, Doppler signal) and has been applied in the 
monitoring of response to treatment, with encouraging 
results. Recent published studies evaluated the sensitivity 
to change of PDUS in the evaluation of the response to 
biological drugs, showing a significant reduction of joint 
inflammation, as evaluated by GS or PD assessment, and 
significant correlations with disease activity indices, such 
as the Disease Activity Score (DAS28) [14-18].  
However, there is lack of consensus concerning 
which target  joints should be assessed, and which scor-
ing system should be adopted [19]. The perspective to 
develop a global US score is very interesting, because 
of the possibility to objectively identify the real level of 
the inflammatory status at joint level, corresponding to 
disease activity of patients affected by inflammatory ar-
thritis. Several differences in terms of number and com-
position of joints evaluated have been identified in the 
studies published until now [19]. The number of joints to 
evaluate and include into a global US scoring system is a 
key issue. The proposed number and composition of re-
duced joint counts were based either on the frequency of 
involvement [20-22], or the representative value of tar-
get joints [23] or the development of logistic regression 
models [24,25]. Almost all analyzed papers included the 
evaluation of at least 6 joints, similarly to the score pro-
posed by Perricone et al [25]. The 2nd metacarpophalan-
geal joints (MCP) and the wrist were included in all com-
posite US scoring systems. 
Another important issue concerning the role of US 
in RA consists of the possibility of identifying subclini-
cal synovitis. It has been demonstrated that US is more 
sensitive than clinical examination in detecting inflamed 
joints [26], being subclinical inflammation not an un-
common feature [27].
In RA the presence of sublinical synovitis in symp-
tom-free joints has been highlighted at hand, wrist, knee 
and foot joints [28-31]. In addition, subclinical synovi-
tis detected by US-PD was shown to be more likely to 
progress to structural damage as bone erosions and joint 
space narrowing [32-34]. Thus US could be a powerful 
tool to exactly assess joint abnormalities in order to bet-
ter classify an apparent clinical remission. The presence 
of subclinical synovitis can be considered as a sign of 
possible RA progression that needs to be monitored pro-
viding useful information to the rheumatologist to decide 
for the best treatment option [28]. 
b) Tenosynovitis
Tenosynovitis is a common feature in patients af-
fected by RA and the tendons assessment is part of US 
assessment. According to OMERACT, tenosynovitis is 
defined as hypoechoic or anechoic thickened tissue with 
or without fluid within the tendon sheath that is seen in 2 
perpendicular planes, and that may exhibit Doppler sig-
nal [6]. Filippucci et al showed that the 2nd and 4th finger 
flexor and the extensor carpi ulnaris tendons were often 
involved in patients affect by RA [35].
Even for tenosynovitis assessment, a GS and PD 
semiquantitative scoring system has been proposed, 
ranging from 0 to 3 (0=normal, 1=mild, 2=moderate and 
3=severe) [36]. As for synovitis, scoring of tenosynovitis 
could be very important in the assessment and monitor-
ing of RA patients during treatment. Despite that, there 
is no consensus on how to score or how many tendons 
should be included in a US scoring system for follow-up. 
In terms of reliability in detecting inflammatory tendon 
abnormalities in patients affected by RA, an excellent 
result has been recently obtained both for GS and PD as-
sessments [37]. 
c) Bursitis
The broad spectrum of RA manifestations includes 
peri-articular soft tissues involvement including syno-
vial bursae. Their inflammation determines important 
pain worsening the quality of life of RA patients. Thus, 
a rapid identification of RA related bursitis can be es-
sential to adopt an appropriate therapy [38]. The role of 
US in detecting bursitis in RA patients has poorly been 
investigated and has been mainly focused on shoulder 
and foot disease [39-45]. At shoulder level subdeltoid 
bursitis can be a cause of pain and functional impairment 
contributing to the global involvement of shoulder in RA 
patients; it is estimated that 70% of RA patients suffer 
from shoulder pain [39]. In a study published in 2008 
painful rheumatoid shoulders were assessed by US-PD in 
order to detect sites of inflammation [39]. One-hundred-
fifty-eight painful RA shoulders were examined detecting 
subdeltoid bursitis in the 35%. Bursitis was highlighted 
when the maximum diameter of the bursa was more than 
2 mm because of the presence of sonolucent fluid with or 
without additional echogenic material inside of it. Previ-
ous studies reported the presence of US-detected subdel-
toid bursitis in 18-69% of rheumatoid shoulders [41,42]. 
Moreover these researches have described the presence 
of isolated subdeltoid bursitis in RA patients without gle-
nohumoral synovitis confirming that this specific inflam-
matory alteration can be the exclusive cause of shoulder 
pain [41]. 
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Another important anatomic site that can be charac-
terized by bursitis is the foot [43]. In particular the pres-
ence of forefoot bursae in RA patients has been recently 
studied [44,45]. Bowen et al reported a prevalence of US 
detectable foot bursae of 92.6% in RA patients. They also 
demonstrated that US was superior to clinical examina-
tion which identified foot bursitis only in 23.5% of pa-
tients [44]. Same authors in 2010 [46] assessed foot of 
RA patients at baseline and after 12 months in order to 
detect forefoot bursae and determine their natural history 
and clinical significance. US detectable foot bursae were 
found in 93.3% of participants at 12 months, this result 
was substantially stable respect to US findings at base-
line. However authors demonstrated a high individual 
variability. Indeed 45% of patients presented a regression 
of one or more bursae, while a similar number had new 
episodes of foot bursitis identified by US. Foot bursitis 
can therefore be considered a dynamic process and its 
identification by US is very important to better focus 
on treatment, as steroid injection, and preventative foot 
health [46]. 
US is a valuable imaging tool to detect bursitis at dif-
ferent articular sites in RA patients [47]. 
Structural damage
a) Erosions
According with the OMERACT US definitions, ero-
sion was defined as an intraarticular discontinuity of the 
bone surface that is visible in 2 perpendicular planes [6]. 
It is now established the superiority of US in terms of 
sensitivity, in the assessment of erosive bone damage, 
compared with X-Ray [48]. In 1999 Backhaus et al found 
that this technique can visualize more erosions than X-
ray in RA patients [49]. In a study conducted on 100 RA 
patients, Wakefield documented the capability of US to 
detect the presence of erosive damage 6.5 times more 
than X-ray [7]. This evidence was further confirmed 
when Magnetic Resonance or Computed Tomography 
were used as the reference method, especially in patients 
with an early phase of the disease [7,50,51]. Standard-
ized scoring systems to evaluate bone erosive damage by 
using US assessment, are not available so far. The ero-
sive damage have been categorized according with the 
number of erosions [52], with the number of joints or 
quadrants showing erosions, or with the dimension of 
the erosions [7,51,53,54]. Moreover, a semiquantitative 
scoring system, ranging from 0 to 3 according with the 
number of erosions was suggested by Lopez-Ben et al 
[55]. The reliability of US in the assessment of erosive 
damage seems good, as demonstrated by several studies. 
Particularly, Wakefield and colleagues demonstrated an 
intra and inter-observer K value of 0.75 and 0.76 respec-
tively in a cohort of RA patients [7]. More recently, Bajai 
obtained better results, demonstrating a K value of 0.98 
in the inter-observer evaluation [52]. 
b) Cartilage
By using X-ray only indirect signs of cartilage dam-
age can be demonstrated. On the contrary, US assessment 
could provide detailed imaging of the hyaline cartilage, 
identifying small cartilage abnormalities in patients af-
fected by RA [56]. US evaluation allows a reliable and 
valid measurement of cartilage at finger joints level, with 
great sensitivity compared to X-ray [57]. A good inter-
observer reproducibility was identified in a study analys-
ing the qualitative morphological modifications of the 
cartilage at MCP joint level in patients affected by RA 
[58]. Further evaluations on larger population are needed 
to better standardize the scoring to assess cartilage dam-
age in RA. 
c) Tendon rupture
Tendon involvement is a common feature in RA. Re-
current episodes of tenosynovitis associated with prolif-
eration of the tenosynovium can lead to tendon structural 
changes as tendon adhesion and rupture causing severe 
articular impairment [59]. Even if US has been indicated 
as the reference imaging technique to evaluate tendons 
[60] up to date the majority of studies concerning US as-
sessment in RA have focused on the detection of joint in-
flammation and bone erosions less than on tendon pathol-
ogy [61-63]. A recent systematic review by Alcalde et al 
analysed the role of US in assessing tendon lesion in RA 
and other inflammatory joint disease. The authors pointed 
out the lack of common agreed definitions to score tendon 
abnormalities and in particular the absence of clear dis-
tinction between partial and compete tendon tear that was 
applied only in few of the studies reviewed (36). Five stud-
ies aimed to identify, beside tenosynovitis, tendon rupture 
[62,64-67]. Four studies were case series and 1 was a co-
hort study. Tendon assessed included wrist extensors, hand 
flexors, ankle tendons and shoulder rotator cuff tendons. 
Not all researches provided US definition of tendon le-
sions, adopting a binary quantification system to describe 
the presence of tendon structural damages, underlining the 
need for further investigation to propose common scoring 
systems [36]. Filippucci et al in 2012 published an ultra-
sonographic study specifically concerning hand tendon 
involvement in RA [35]. Ninety patients were enrolled 
assessing hand flexors and wrist extensors. Tendon dam-
age was defined as the presence of tendon echostructure 
derangement, evidenced as the loss of homogeneity in 
tendon fibrillar structure due to edema, partial tear and 
complete rupture, identified when a focal discontinuity 
or the complete loss of substance was visualized with the 
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US beam exactly perpendicular to the tendon to avoid ani-
sotropy [61,68]. Tendon damage was found in at least 1 
anatomic site in 43.3% of patients assessed. Particularly, 
among the 5400 tendons assessed, echostructure derange-
ment, partial tear and complete rupture were retrieved in 
5.4%, 3.3% and 0.6% of RA tendons, respectively [35]. At 
wrist level, the tendons most frequently involved resulted 
to be the 1st and 6th compartment extensor tendons. In par-
ticular the extensor carpi ulnaris tendon presented more 
frequently signs of partial tear or complete rupture. This is 
a well known feature of RA which has in the tendons of the 
6th extensor compartment a target of the disease [69]. This 
study evidenced the utility of US examination in detect-
ing tendon pathology that can easily be misdiagnosed with 
only clinical examination [61], however concluded that 
more researches are needed to define the most commonly 
involved tendon sites to focus US examination on target 
tendons in RA [35]. In conclusion US can be considered 
a useful tool to assess tendon damage but more consensus 
on definitions as well as careful consideration on training 
and standardization of tendon pathology US assessment is 
required [37,67]. 
Main applications 
The main applications of US in the assessment of pa-
tients affected by RA include the monitoring of response 
to treatment and the guide for intra-articular procedures 
[70]. In the last years, US was widely applied in the as-
sessment of the response to treatment with different 
drugs, especially in patients treated with biological ther-
apy. The administration of tumor necrosis factor alpha 
(TNF)-antagonists determines an improvement of syno-
vitis, in terms of PD signal. First, Hau and colleagues 
observed a significant reduction of the numbers of Dop-
pler signals at MCP level in 5 RA patients [71]. From 
2005, when OMERACT definitions were published, 12 
studies evaluated the efficacy of anti-TNF drugs by using 
US assessment [11,16,17,21,24,25,72-77]. The number 
of patients enrolled in the studies was variable, ranging 
from 18 to 278 patients. Moreover, a wide variability was 
identified regarding the therapy assumed by the enrolled 
patients (etanercept, adalimumab, infliximab) and the 
follow-up, ranging from 12 weeks and 24 months. The 
number of joints evaluated was variable: some studies 
included a single joint (wrist) [75], other studies evalu-
ated a great number of articular sites (78 joints assessed 
in the study conducted by Hammer et al in 2010) [77]. 
All studies demonstrated a significant reduction of US 
score after treatment with TNF-antagonist, irrespective 
of the follow-up. Moreover, a significant correlation with 
disease activity indices was identified. 
Intra-articular injections of different drugs could be 
an important approach in the patients with monoarthritis, 
with a rapid and effective control of inflammatory sta-
tus. The US guidance resulted in significantly improved 
results, in terms of performance, increased of responder 
rate, and increased amount of fluid detected and aspirated 
[78,79]. The most frequently used drugs in patients with 
RA are corticosteroids. However, different drugs were in-
tra-articular administered in patients with monoarthritis 
refractory to corticosteroids. US could be used by guide 
during intra-articular procedure, but also in monitoring 
the response to treatment. In 2006, Iagnocco et al demon-
strated by using US the efficacy of intra-articular admin-
istration at the knee level of Methotrexate in 10 patients 
affected by RA [80]. More recently intra-articular admin-
istration of TNF-antagonist infliximab showed encourag-
ing results in the great majority of cases [81]. 
Additional applications
The utility of US joint examination has been evidenced 
in early arthritis patients. Rheumatologists know how im-
portant could be making early diagnosis in order to adopt 
a tight control of disease activity so to modify the natural 
history of RA. US was demonstrated an important imag-
ing modality to achieve these objectives [82]. Actually 
US has been shown to be superior to clinical examination 
in detecting synovitis in early RA [70,83]. Such a result 
suggests that a US count of inflamed joints can be use-
ful to discriminate oligoarthritis from polyarthritis with 
consequent fundamental prognostic implications [27]. 
Even to detect bone erosions US was proved more sensi-
tive than X-Rays, depicting them before the evidence on 
radiograms [7,48,50]. Moreover the presence of high GS 
score, PD signal and at least one erosion at early stage 
of disease have been associated with an increased prob-
ability of persistent inflammatory arthritis, including RA 
[84]. Particularly, evidence of erosion at the radial part 
of 2nd MCP, ulnar part of 5th MCP and fibular part of 5th 
metatarsophalangeal joint (MTP) are typical of RA [85].
So their detection seems important in order to adopt the 
most appropriate therapeutic management of patients. US 
examination performed at early stage of disease can also 
help clinicians in making a correct differential diagnosis, 
in fact the presence of enthesal pathology, especially at 
sub-clinical level, can lead more easily to a diagnosis of 
spondyloarthropaty [86]. On the other hand early signs of 
inflammation of extensor carpi ulnaris have a high pre-
dictive value for the development of erosive damage in 
RA [69]. Furthermore joint US in early arthritis can be 
useful to properly define clinical remission. US was dem-
onstrated to identify sub-clinical inflammation in patients 
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considered in remission and the presence of positive PD 
signal presented an increased risk of relapse and progres-
sion of disease [87]. This stresses that US assessment may 
be important to classify patients in order to better decide 
on their treatment. Further studies are needed to define 
the role of US in the prediction of RA in patients with 
very early synovitis even if it has been demonstrated to be 
a useful tool especially when GS and PD scanning were 
performed on MCP, wrist and MTP joints [88].
Finally, is important to underline the role of US in 
assessing articular and peri-articular inflammation in ju-
venile arthritis. US, even in children, has demonstrated 
higher sensitivity in detecting synovial inflammation and 
structural damages than clinical examination (89). More-
over US is a rapid, cheap and bedside imaging modal-
ity well accepted by young patient that does not require 
anaesthesiological support, as with magnetic resonance, 
and does not use radiations which can badly affect chil-
dren’s tissues [89].
Future perspectives
Several future perspectives concern the US in the 
evaluation of patients affected by RA. First, new technol-
ogies, as 3-dimensional technique and fusion imaging, 
have been applied in pilot studies, showing higher reli-
ability compared with two-dimensional methods [90,91]. 
Moreover, the use of contrast-enhanced US seems to 
provide significantly higher sensitivity than PD-US in 
the identification of abnormal vascularization in joint in-
flammation, allowing a more exact measurement of the 
synovitis, as well as a quantitative assessment of inflam-
mation by using the analysis of time-intensity curves. 
However, its place and benefits in management of RA 
patients is not yet clearly established and larger studies 
are needed to better clarify this issue [92]. 
More recently, few studies have analysed the correla-
tion between synovitis, assessed by using US technique, 
and biomarkers. Hammer et al evaluated the correlation 
between the soluble biomarker calprotectin and synovitis, 
showing significant results: calprotectin was associated 
with the sum scores from a comprehensive US assessment 
and was responsive to change during anti-TNF treatment 
[93]. In 2011, we demonstrated that TGF-β 869C/T sin-
gle nucleotide polymorphism could influence the bone-
erosive damage as evaluated by US, with a dichotomic 
behaviour according with the autoantibody status [94].
Conclusions
US is an imaging method that has recently entered 
in the clinical practice of rheumatologists as a comple-
mentary tool to the clinical assessment of RA.  It allows 
an improvement of the quality of diagnostic and treat-
ment decisions. The higher sensitivity of US examina-
tion in the detection of erosive bone damage in RA pa-
tients, compared with X-ray is now known, especially 
in the early stages of the disease. In the current state, a 
unique scoring system optimal for follow-up the inflam-
matory status in RA patients is not available, but several 
researches are addressed to identify a feasible and reli-
able system, able to replace clinical or composite scores. 
Finally, several interesting future perspectives, re-
garding new techniques and the correlations with bio-
markers, should be applied in the researches.  However, 
the possible use in the clinical practice of these new per-
spectives should be verified.
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